YD Bio Limited fell 16.9% on Friday, November 6, 2026, on 206,967 shares. No headline about YDES came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
YD Bio Limited (YDES:NASDAQ) closed at $5.97 on November 6, 2026, down 16.85% on the day. The stock trades 62.0% below its 52-week high of $15.72 and 251.2% above its 52-week low of $1.70. Over the past year, it lost 31.1%. YD Bio Limited is part of the Health Care sector.
In 252 trading sessions since November 6, 2025, YDES closed higher on 116 days (46%). Its best day was September 24, 2026 (+47.68%) and its worst was October 22, 2026 (-26.52%). The stock moved 10% or more in a single session 46 times. It opened at least 5% above the previous day's high 4 times.
YD Bio Limited is a biotechnology company pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. Our mission is to redefine healthcare by making breakthrough diagnostics and regenerative therapies accessible to patients everywhere.
Find more stocks like YDES with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.